Qube Research & Technologies (QRT)
ATRS

Qube Research & Technologies (QRT)’s Antares Pharma, Inc. ATRS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-88,984
Closed -$366K – 2987
2021
Q1 		$366K Buy
+88,984
New +$386K 0.01% 1352
2020
Q3 		– Sell
-89,883
Closed -$247K – 2240
2020
Q2 		$247K Buy
89,883
+71,988
+402% +$201K ﹤0.01% 1368
2020
Q1 		$42K Sell
17,895
-20,765
-54% -$70.6K ﹤0.01% 1023
2019
Q4 		$182K Buy
+38,660
New +$158K 0.01% 1410

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ATRS Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 88,984 shares — an estimated $366K sold.

Qube Research & Technologies (QRT) first reported a position in ATRS in Q4 2019 and held it in 4 quarters. The position peaked at $366K in Q1 2021. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 88,984 Antares Pharma, Inc. shares in Q2 2021, an estimated $366K.
  • Qube Research & Technologies (QRT) first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Antares Pharma, Inc. position peaked at $366K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.